Industry News
Biotechnology Industry News
PepGen raises $113M to challenge Sarepta in DMD, build neuromuscular and neurologic pipeline
PepGen raises $113M to challenge Sarepta in DMD, build neuromuscular and neurologic pipeline ntaylor Wed, 08/04/2021 - 11:22
Pfizer’s ritlecitinib hits goal in alopecia phase 3, setting up showdown with Lilly
Pfizer's ritlecitinib hits goal in alopecia phase 3, setting up showdown with Lilly ntaylor Wed, 08/04/2021 - 08:20
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study ntaylor Wed, 08/04/2021 - 07:27
Another one BiTEs the dust as Amgen pauses enrollment for phase 1 bispecific trial
Another one BiTEs the dust as Amgen pauses enrollment for phase 1 bispecific trial ntaylor Wed, 08/04/2021 - 07:27
How a century-old tuberculosis vaccine may help fight severe COVID-19
How a century-old tuberculosis vaccine may help fight severe COVID-19 aliu Wed, 08/04/2021 - 06:12
Pitt’s inhalable anti-COVID nanobodies, inspired by llamas, ‘remarkably active’ against delta variant: study
Pitt's inhalable anti-COVID nanobodies, inspired by llamas, 'remarkably active' against delta variant: study arlene.weintraub Tue, 08/03/2021 - 10:37
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval in depression
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval in depression ntaylor Tue, 08/03/2021 - 07:58
With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal
With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal ntaylor Tue, 08/03/2021 - 03:59
Unleashing immunotherapy against ‘cold’ prostate tumors with a new protein target
Unleashing immunotherapy against 'cold' prostate tumors with a new protein target arlene.weintraub Mon, 08/02/2021 - 09:15
Moderna looks to Autolus to further fuel its mRNA oncology plans
Moderna looks to Autolus to further fuel its mRNA oncology plans ntaylor Mon, 08/02/2021 - 08:20
T-knife Therapeutics bags $110M to sharpen solid tumor cell therapy push into the clinic
T-knife Therapeutics bags $110M to sharpen solid tumor cell therapy push into the clinic ntaylor Mon, 08/02/2021 - 06:21
Takeda allies with Frazier to spin out late-phase norovirus vaccinei
Takeda allies with Frazier to spin out late-phase norovirus vaccinei ntaylor Fri, 07/30/2021 - 06:50
Takeda allies with Frazier to spin out late-phase norovirus vaccine
Takeda allies with Frazier to spin out late-phase norovirus vaccine ntaylor Fri, 07/30/2021 - 06:50
Ardelyx’s FDA rejection points to long path back for CKD drug
Ardelyx's FDA rejection points to long path back for CKD drug ntaylor Fri, 07/30/2021 - 06:47
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work badams Fri, 07/30/2021 - 05:11
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbocharge work
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbocharge work badams Fri, 07/30/2021 - 05:11
Rakuten Medical rakes in $166M series D following drug-device combo’s approval in Japan
Rakuten Medical rakes in $166M series D following drug-device combo's approval in Japan klahucik Thu, 07/29/2021 - 10:55
People of color want to participate in Alzheimer’s research. The NIA has a new tool to make it happen
People of color want to participate in Alzheimer's research. The NIA has a new tool to make it happen klahucik Thu, 07/29/2021 - 10:19
Immune system protein prompts obese mice to ‘sweat’ out fat, inspiring new treatment target
Immune system protein prompts obese mice to 'sweat' out fat, inspiring new treatment target arlene.weintraub Thu, 07/29/2021 - 09:48
Eli Lilly bets $70M upfront and another $2B in biobucks for Kumquat’s immuno-oncology small molecules
Eli Lilly bets $70M upfront and another $2B in biobucks for Kumquat's immuno-oncology small molecules ntaylor Thu, 07/29/2021 - 08:19